Member Info for LUCAN

Seems to be still a substantial seller?

This is a fine company. However, if you look back to the last spike (2019) you will find that it was punctured by a placing within a week. The same is very likely to happen this time - the company will need funds within 6 months, so why should they wait?

It occurs to me to wonder whether you have ever had any thanks from the directors for the 6,000 hours of research, and all the associated posting. I have been here for 8 years. In that time I have been in and out of probably a hundred other companies, most of them best forgotten. I never would have held on here without the steady and rational encouragement your posts have offered. Most of that time I have been under water, though I am well in profit now. My holding is not enough to make any difference to the company, but I know there are dozens who could tell the same story, and it all adds up. I hope you are right about the endgame - I nearly believe it now - but even if not, you are due a general vote of thanks.

potnak, thks

LSE seems to have frozen completely for about 2 hrs.
Can anyone supply a more recent price than 2.25? Maybe that's still the price but I doubt it.

Some people are making loadsamoney here.
Others are losing, unftly.

I second that.

The share price has risen more than 50% over two days, with no news.
Presumably the board will have to say they know of no reason - unless of course they do know of a reason.

Probably the same seller that has been driving BMN shares down. They would have received an ATM stake when it demerged from BMN. Seems they want cash, irrespective of what it does to the share price. Pretty brutal.

'An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live").[1] Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent.'
So, less virulent, thus more effective to our purpose. Agreed?

According to my Chambers dictionary, 'attenuate' means to make thin or lean, to reduce in strength or value. Not to increase effectiveness, then.

It sounds as though you are new to investing. Nothing wrong with that, we all had to begin. However, there are a few things you should learn - if possible, not by bitter experience.
First, there is no share that only goes up. If you look at the charts, you will see that Sareum has been at 1.5p before, more than once. It came down again sharpish. This time may be different - or maybe not.
#Thoth is a smart fellow, and I pay attention to his views. However, it is fair to say that he has been quoting ambitious targets for SAR, for quite a while now - and they haven't happened, yet. Maybe this time is different.
If you are showing a decent profit, it is often wise to take some of your money off the table - so that you are not completely exposed if the market turns the other way.
With best wishes,no offence meant.

So far as I can see, the situation is as follows.
1. Next news, hopefully, will be one or more contract wins from the Eskom tenders.
2. On the back of that, we may see the Johannesburg stock launch, with or without a move from AIM.
3. If this boosts the share price, possibility of some financial engineering to conclude the Vanchem purchase.
Where will we be after all that? Hopefully a good bit higher. In the meantime, sit tight.

Surely this cannot continue to rise without further significant news.
I know there are interesting prospects, but even so ...

The facts are, pharmaceutical buy-out prices are rarely more than a 100% premium on the previous mcap or share price. Anything more is very rare. Usually it's somewhat less. Stubborn things, facts.

I would hazard a guess they will miss the end September deadline.

It is getting on for three years now since I bought shares here.
I repeat, it is all taking far too long.

Unfortunately this is all taking far too long. There seems to be no real sense of urgency.
Meanwhile the world is moving on, other companies are developing rival treatments, and the unfortunate patients are deprived of what could be a life saving treatment.

I do not believe Higgs was the loser.

The difference is that Largo is a pure mining play, whereas at BMN, the picture is clouded by energy storage. Rightly or wrongly, the market does not regard that as a positive.